An ideal product for mild to moderate body acne treatment

Instant Rebate

Pay No More than $25 For BenzEFoam™ Emollient Foam*

Register below to print your BenzEFoam™ Emollient Foam Instant Rebate Coupon and pay no more than $25 for your BenzEFoam™ Emollient Foam prescription. Insured patients and the majority of patients paying with cash can take advantage of this instant savings. Keep the instant rebate coupon for future use, as it can be used up to three times.

*Please read IMPORTANT NOTICE on back of coupon to determine if you are eligible for this offer. This offer is void where prohibited by law.

Onset Therapeutics is committed to protecting and safeguarding your privacy. Please read our Privacy Policy to understand how we use the information you provide from this site. We will not sell your information, and you will not receive anything from us that you have not agreed to receive.

* Required fields

First name^*

Last name^*

Email^*

Confirm email^*

Address

Address (continued)

City

State

Zip code

Gender^*

Male
Female

Do you suffer from acne?^*

Yes
No
Child has acne

I would like to receive information on acne, skincare tips, and special offers from BenzEFoam™ Emollient Foam.

By checking this box, I confirm I am 13 years of age or older.^*

The BenzEFoam™ Difference

What makes this
an ideal product for
mild to moderate body acne?

Learn More

Please see full
Patient Information

View Here

Important Safety Information

BenzEFoam™ Emollient Foam should not be used on patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. Allergic contact dermatitis and dryness have been reported with topical benzoyl peroxide therapy. When using this product, avoid unnecessary sun exposure and use a sunscreen. BenzEFoam™ Emollient Foam, like all benzoyl peroxide containing products, may bleach hair or colored fabrics.

Please see full Prescribing information.

BenzEFoam™ Emollient Foam is indicated for use in the topical treatment of mild to moderate acne vulgaris

This site is published by Onset Therapeutics, which is solely responsible for its contents. This site intended for U.S. residents only.

Please see our Privacy Policy.

Site last updated: September 25, 2009.